Product information
From Health Canada
Current status:
Marketed
Current status date:
2013-04-20
Original market date: See footnote 1
1950-12-31
Product name:
NEO-LARYNGOBIS
DIN:
00065927 Electronic product monograph is not available
Company:
TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Suppository
Route(s) of administration:
Rectal
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
52:92.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R02AA20 VARIOUS
Active ingredient group (AIG) number:See footnote5
0108681002
Active ingredient(s) | Strength |
---|---|
BISMUTH DIPROPYLACETATE | 135 MG |